A research team has found a way to restore brain communication and memory function in mice — offering real hope that ...

For decades, Alzheimer’s disease has been like an unbreakable fortress. Scientists have tried everything to chip away at the sticky clumps of beta-amyloid proteins that build up in the brain — a toxic ...

The nanoparticles act as tiny engineers of cellular behavior, the researchers explain, orchestrating repair at the molecular ...

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky clumps of toxic protein that accumulate in the brain. Now, a new ...

Alzheimer’s disease has been reversed in mice in a breakthrough that offers hope that the disease may one day be curable.

A new study provides a well-needed glimmer of hope for treating Alzheimer’s disease. Focusing on a genetic form of early-onset dementia called dominantly inherited Alzheimer’s disease, scientists have ...

Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia. Turns out that the answer may lie within our own brains. Researchers from ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s dementia can delay the ...

Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in the ...

Although there are many outstanding questions about Alzheimer’s and a significant lack of effective drugs, scientists believe a protein called amyloid-beta plays an important role in the condition.

A recent study tests a new drug, gantenerumab on people with a genetically inherited form of Alzheimer’s disease. For people with this condition, dementia is almost inevitable. Gantenerumab helps ...